Carmen Chillón

4.0k total citations
76 papers, 1.5k citations indexed

About

Carmen Chillón is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Carmen Chillón has authored 76 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hematology, 31 papers in Molecular Biology and 24 papers in Genetics. Recurrent topics in Carmen Chillón's work include Acute Myeloid Leukemia Research (27 papers), Chronic Lymphocytic Leukemia Research (18 papers) and Multiple Myeloma Research and Treatments (17 papers). Carmen Chillón is often cited by papers focused on Acute Myeloid Leukemia Research (27 papers), Chronic Lymphocytic Leukemia Research (18 papers) and Multiple Myeloma Research and Treatments (17 papers). Carmen Chillón collaborates with scholars based in Spain, United States and United Kingdom. Carmen Chillón's co-authors include Marcos González, Ramón García‐Sánz, Jesús F. San Miguel, Ana Balanzategui, María Eugenia Sarasquete, Miguel Alcoceba, Norma C. Gutiérrez, Jesús María Hernández‐Rivas, Luis Marı́n and Ricardo López‐Pérez and has published in prestigious journals such as Blood, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Carmen Chillón

74 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmen Chillón Spain 25 793 715 387 354 308 76 1.5k
María Eugenia Sarasquete Spain 26 837 1.1× 971 1.4× 608 1.6× 401 1.1× 337 1.1× 80 1.9k
Martin Jädersten Sweden 22 1.7k 2.1× 857 1.2× 263 0.7× 795 2.2× 185 0.6× 63 2.1k
Ana Balanzategui Spain 25 491 0.6× 440 0.6× 459 1.2× 492 1.4× 539 1.8× 70 1.5k
Bertil Uggla Sweden 14 600 0.8× 485 0.7× 414 1.1× 195 0.6× 159 0.5× 31 1.1k
Jan B. Egan United States 16 709 0.9× 868 1.2× 448 1.2× 216 0.6× 436 1.4× 34 1.6k
Mario Masi Italy 17 1.1k 1.4× 488 0.7× 220 0.6× 429 1.2× 331 1.1× 23 1.6k
Michal Bar‐Natan United States 15 719 0.9× 524 0.7× 312 0.8× 364 1.0× 149 0.5× 41 1.3k
James S. Blachly United States 26 778 1.0× 770 1.1× 270 0.7× 560 1.6× 305 1.0× 126 1.6k
H Kantarjian United States 16 594 0.7× 310 0.4× 310 0.8× 501 1.4× 288 0.9× 28 1.2k
Annamaria Brioli Italy 20 1.8k 2.2× 1.3k 1.9× 954 2.5× 255 0.7× 167 0.5× 72 2.2k

Countries citing papers authored by Carmen Chillón

Since Specialization
Citations

This map shows the geographic impact of Carmen Chillón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Chillón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Chillón more than expected).

Fields of papers citing papers by Carmen Chillón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Chillón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Chillón. The network helps show where Carmen Chillón may publish in the future.

Co-authorship network of co-authors of Carmen Chillón

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Chillón. A scholar is included among the top collaborators of Carmen Chillón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Chillón. Carmen Chillón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alcoceba, Miguel, Miguel Marcos, Francisco Javier Gil‐Etayo, et al.. (2024). Killer‐cell immunoglobulin‐like receptor polymorphism is associated with COVID‐19 outcome: Results of a pilot observational study. HLA. 104(2). e15640–e15640. 1 indexed citations
2.
Rodríguez‐Macías, Gabriela, Óscar Briz, Candela Cives-Losada, et al.. (2023). Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy. Cancers. 15(12). 3145–3145. 2 indexed citations
3.
García‐Álvarez, María, Cristina Jiménez, Alejandro Medina, et al.. (2023). Single-Cell DNA Sequencing and Immunophenotypic Profiling to Track Clonal Evolution in an Acute Myeloid Leukemia Patient. Biomedicines. 12(1). 66–66. 2 indexed citations
4.
Boix, Francisco, Luis Marı́n, Miguel Alcoceba, et al.. (2021). Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain. Human Immunology. 82(8). 549–550. 2 indexed citations
5.
Vázquez, Iria, María José Larráyoz, Ramón García‐Sánz, et al.. (2020). Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design. PLoS ONE. 15(1). e0227986–e0227986. 30 indexed citations
6.
Corchete, Luís A., María García‐Álvarez, Cristina Jiménez, et al.. (2019). A New Next-Generation Sequencing Strategy for the Simultaneous Analysis of Mutations and Chromosomal Rearrangements at DNA Level in Acute Myeloid Leukemia Patients. Journal of Molecular Diagnostics. 22(1). 60–71. 10 indexed citations
7.
Jiménez, Cristina, María García‐Álvarez, Miguel Alcoceba, et al.. (2018). Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study. Annals of Hematology. 97(3). 475–484. 17 indexed citations
8.
Jiménez, Cristina, Carmen Chillón, Ana Balanzategui, et al.. (2014). Detection of MYD88 L265P Mutation by Real-Time Allele-Specific Oligonucleotide Polymerase Chain Reaction. Applied immunohistochemistry & molecular morphology. 22(10). 768–773. 17 indexed citations
9.
Santamaría, Carlos, Fernando Ramos, Noemí Puig, et al.. (2012). Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival. Annals of Hematology. 91(12). 1887–1895. 12 indexed citations
10.
Barragán, Eva, Pau Montesinos, Mireia Camós, et al.. (2011). Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy. Haematologica. 96(10). 1470–1477. 39 indexed citations
11.
Alcoceba, Miguel, Luis Marı́n, Ana Balanzategui, et al.. (2011). Frequency of HLA‐A, ‐B and ‐DRB1 specificities and haplotypic associations in the population of Castilla y León (northwest‐central Spain). Tissue Antigens. 78(4). 249–255. 10 indexed citations
12.
Gutiérrez, Norma C., María Eugenia Sarasquete, Irena Misiewicz-Krzemińska, et al.. (2010). Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling. Leukemia. 24(3). 629–637. 169 indexed citations
13.
Sayagués, José María, Celia Fontanillo, M. Abad, et al.. (2010). Mapping of Genetic Abnormalities of Primary Tumours from Metastatic CRC by High-Resolution SNP Arrays. PLoS ONE. 5(10). e13752–e13752. 23 indexed citations
14.
Santamaría, Carlos, Carmen Chillón, Ramón García‐Sánz, et al.. (2009). BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML). Annals of Hematology. 89(5). 453–458. 35 indexed citations
15.
Sarasquete, María Eugenia, Ramón García‐Sánz, Luis Marı́n, et al.. (2008). Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis. Blood. 112(7). 2709–2712. 164 indexed citations
16.
Tabernero, María Dolores, Ana Rasillo, José María Sayagués, et al.. (2003). Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities. Leukemia. 17(6). 1124–1129. 48 indexed citations
17.
Mateos, María‐Victoria, Marcos González, Ana Balanzategui, et al.. (2000). Status of methylation of p16 gene in multiple myeloma: a comparative study of three methods for its detection. Clinical Biochemistry. 33(5). 415–418. 4 indexed citations
18.
González, Marcos, Ramón García‐Sánz, Ana Balanzategui, et al.. (2000). De novo methylation of tumor suppressor gene p16/INK4a is a frequent finding in multiple myeloma patients at diagnosis. Leukemia. 14(1). 183–187. 51 indexed citations
19.
López‐Pérez, Ricardo, Ramón García‐Sánz, David González, et al.. (2000). The detection of contaminating clonal cells in apheresis products is related to response and outcome in multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Leukemia. 14(8). 1493–1499. 17 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026